First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
Thesis: Smith & Nephew: the story is balanced — Elective surgery volumes in orthopedics (hip/knee replacements), which correlate with hospital capacity…
value - The stock trades at 2.5x sales and 12.4x EV/EBITDA, below med-tech peers…
Rising rates have modest negative impact through two channels: (1) higher financing costs for hospital capital equipment purchases…
Watch on earnings: US elective orthopedic procedure volumes (hip/knee replacement trends from CMS data and orthopedic surgeon surveys), CORI robotic system installed base and quarterly placements vs. Stryker Mako competitive data, Emerging market revenue growth rates, particularly China orthopedic market penetration.
One Sentence Summary:
Smith & Nephew: the story is balanced — elective surgery volumes in orthopedics (hip/knee replacements), which correlate with hospital capacity, patient confidence.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.